Viewing Study NCT05721651


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-20 @ 11:49 PM
Study NCT ID: NCT05721651
Status: RECRUITING
Last Update Posted: 2023-04-12
First Post: 2023-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study
Sponsor: Wu Jun
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module